This federal contract award is a delivery order worth $2,103.97 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Naltrexone 50 mg tablets, a medication used in the treatment of substance abuse disorders. The contract has an ultimate completion date of December 19, 2023 and is a firm fixed-price type contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.
Generated 5/13/25, 10:01 AM